Novavax Vaccine Progress Pipeline | Novavax
WEBNovavax continues to optimize preclinical candidates, including a new approach to H5N1 bird flu vaccination. In addition, we are seeking to expand our core technology to new targets and novel applications including mucosal …
Novavax 2024-2025 Formula COVID-19 Vaccine Available at …
WEBAug 30, 2024 · The Company's portfolio includes its COVID-19 vaccine and its pipeline includes a vaccine for influenza and COVID-19 and influenza combined. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine.
Novavax Continues to Partner with the U.S. FDA on Review of …
WEBAug 22, 2024 · Novavax and the U.S. Food and Drug Administration (FDA) are working together productively as the U.S. FDA continues its review of data in consideration of an Emergency Use Authorization (EUA) of Novavax’s 2024-2025 formula COVID-19 vaccine (NVX-CoV2705).
WEBMay 10, 2024 · Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M …
Novavax Submits Application to U.S. FDA for Updated Protein …
WEBJun 14, 2024 · Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement …
WEBMay 10, 2024 · The Company's portfolio includes its COVID-19 vaccine and its pipeline includes its COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's...
Novavax 2024-2025 Formula COVID-19 Vaccine Available at
WEB6 days ago · Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax’s patented Matrix-M adjuvant to enhance the immune response. The Company’s portfolio includes its COVID …
FDA Authorizes Updated Novavax COVID-19 Vaccine to Better …
WEBAug 30, 2024 · FDA authorized for emergency use Novavax COVID-19 Vaccine (2024-2025 Formula) to more closely target currently circulating variants to provide better protection against serious consequences of ...
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized …
WEBJun 27, 2024 · The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine.
Novavax Submits Application to U.S. FDA for Updated Protein …
WEBJun 14, 2024 · The Company's portfolio includes its COVID-19 vaccine and its pipeline includes CIC and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of …
- Some results have been removed